Skip to main content
DNA Labs India

NRXN1 Gene Pitt-Hopkins syndrome NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

NRXN1 Gene Pitt-Hopkins syndrome NGS Genetic Test

Short Name: NRXN1 NGS

Also known as: NRXN1 Gene Sequencing, Pitt-Hopkins Syndrome Genetic Test, NRXN1 Mutation Analysis

NRXN1 Gene Pitt-Hopkins syndrome NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are typically available within 3 to 4 weeks after the sample reaches the laboratory.. Free home collection in 300+ cities across India.

NGS🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to confirm or rule out a diagnosis of Pitt-Hopkins syndrome by identifying pathogenic variants in the NRXN1 gene. It is also used for carrier testing in at-risk family members and for prenatal diagnosis in families with a known NRXN1 mutation.

Test Code
5902
CPT Code
81407
ICD Code
Q87.89
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Reports are typically available within 3 to 4 weeks after the sample reaches the laboratory.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation is required. However, a genetic counseling session is recommended before the test to discuss the implications and obtain informed consent.

Method: Venipuncture or FTA card spot

Step 2

Laboratory Analysis

A blood sample will be drawn by a trained phlebotomist. For FTA card, a few drops of blood will be placed on the card.

Step 3

Report Delivery

No specific precautions are needed. The sample will be transported to the laboratory for analysis.

Timeline: Reports are typically available within 3 to 4 weeks after the sample reaches the laboratory.

Patient Instructions

1
Before the Test:Before the test, a genetic counseling session is recommended to discuss the purpose, risks, benefits, and potential outcomes of the test. The counselor will also draw a pedigree chart to assess inheritance patterns.
2
During the Test:The test involves a simple blood draw or FTA card sample collection. The sample is then sent to the laboratory for NGS analysis.
3
After the Test:After the test, you will receive a detailed clinical report. A genetic counselor will explain the results and their implications for management and family planning.

About This Test

Who Should Get This Test

The purpose of this test is to confirm or rule out a diagnosis of Pitt-Hopkins syndrome by identifying pathogenic variants in the NRXN1 gene. It is also used for carrier testing in at-risk family members and for prenatal diagnosis in families with a known NRXN1 mutation.

How to Prepare

  • Ensure the patient's identity is verified
  • Use EDTA vacutainer for blood collection
  • For FTA card, apply blood drops to the designated circles
  • Label the sample with patient's name and date of birth
  • Transport the sample at ambient temperature

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"Early genetic confirmation of Pitt-Hopkins syndrome is crucial for appropriate management and family counseling. NGS provides comprehensive analysis of the NRXN1 gene."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume2-3 ml blood or 5 µg DNA
ContainerEDTA vacutainer or FTA card
Collection MethodVenipuncture or FTA card spot

Sample Stability

Blood: 7 days at 2-8°C
Extracted DNA: 6 months at -20°C
FTA card: 1 year at room temperature
Sample Rejection Criteria:
  • Hemolyzed blood sample
  • Clotted blood sample
  • Insufficient sample volume
  • Improper labeling
  • Sample received after prolonged transit time

Understanding Your Results

The interpretation of the NRXN1 gene NGS test is based on the detection of pathogenic or likely pathogenic variants in the NRXN1 gene. The presence of such variants confirms the diagnosis of Pitt-Hopkins syndrome. If no variants are found, the test is considered negative, but clinical suspicion may warrant further testing.
📊

Positive

A pathogenic or likely pathogenic variant in NRXN1 was detected, confirming the diagnosis of Pitt-Hopkins syndrome.

📊

Negative

No pathogenic variants were detected in the NRXN1 gene. This does not exclude the possibility of other genetic causes.

📊

Variant of Uncertain Significance (VUS)

A variant was found whose clinical significance is unknown. Further family segregation studies may be recommended.

⚠️ When to Consult a Doctor:

If you or your child have symptoms suggestive of Pitt-Hopkins syndrome, such as developmental delay, intellectual disability, seizures, or breathing abnormalities, consult a clinical geneticist or pediatric neurologist for evaluation and genetic testing.

Limitations

  • This test does not detect large deletions/duplications (CNVs) unless specifically requested
  • Variants in genes other than NRXN1 that may cause similar phenotypes are not analyzed
  • Variant of uncertain significance (VUS) may be reported; further family studies may be needed
  • Mosaic mutations may not be detected with standard NGS
  • Regulatory regions and deep intronic variants are not covered

Risks & Considerations

  • No significant physical risks associated with blood draw
  • Possible bruising or discomfort at the puncture site
  • Psychological impact of receiving a genetic diagnosis
  • Potential for variants of uncertain significance causing anxiety

Interfering Factors

  • Poor DNA quality or quantity
  • Contamination during sample collection
  • Presence of maternal cell contamination in prenatal samples
  • Rare variants in non-coding regions not covered by NGS

Compare With Similar Tests

TestNRXN1 Gene Pitt-Hopkins syndrome NGS Genetic TestChromosomal Microarray (CMA)Whole Exome Sequencing (WES)Sanger Sequencing
ComparisonNRXN1 Gene Pitt-Hopkins syndrome NGS Genetic TestCMA detects copy number variations (deletions/duplications) across the genome, but does not detect single nucleotide variants. NRXN1 NGS specifically sequences the gene for point mutations.WES analyzes all coding regions of the genome, while NRXN1 NGS focuses only on the NRXN1 gene. WES is more comprehensive but more expensive and time-consuming.Sanger sequencing is the gold standard for confirming specific variants, but it is limited to known mutations. NGS can detect novel variants across the entire gene.

Frequently Asked Questions

What is the cost of the NRXN1 Gene Pitt-Hopkins syndrome NGS test?
The test costs INR 20000 at DNA Labs India, which includes home sample collection and a comprehensive clinical report.
What sample is required for this test?
The sample can be blood (2-3 ml in EDTA), extracted DNA, or one drop of blood on an FTA card.
How long does it take to get the results?
The turnaround time is 3 to 4 weeks from the date the sample is received at the laboratory.
Is fasting required before the test?
No, fasting is not required for this genetic test.
Will I receive raw data files?
Yes, DNA Labs India provides raw data files (FASTQ, VCF) along with the clinical report for transparency.
Can this test detect all types of NRXN1 mutations?
The test detects single nucleotide variants and small insertions/deletions in the coding regions and splice sites. Large deletions/duplications are not detected unless specifically requested.
Is genetic counseling included?
Yes, a genetic counseling session is included to draw a pedigree chart and discuss the implications of the test.
What is Pitt-Hopkins syndrome?
Pitt-Hopkins syndrome is a rare genetic disorder characterized by intellectual disability, developmental delay, seizures, breathing abnormalities, and distinctive facial features, caused by mutations in the NRXN1 gene.
Who should consider this test?
Individuals with symptoms suggestive of Pitt-Hopkins syndrome, such as intellectual disability, developmental delay, seizures, and dysmorphic features, or those with a family history of NRXN1 mutations.
Is home sample collection available?
Yes, we offer free home sample collection for online bookings across major cities in India.
What is the accuracy of this test?
The test is highly accurate with a sensitivity and specificity of over 99% for detecting pathogenic variants in the NRXN1 gene.
Can this test be used for prenatal diagnosis?
Yes, if a pathogenic variant is known in the family, this test can be used for prenatal diagnosis using appropriate samples like amniotic fluid or chorionic villi.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.